IDIBAPS Respiratory Research Group - IAMR - News

IAMR researcher Dr. Miravitlles launched the book "EPOC: Diagnóstico diferencial" along with Dr. Josep Morera

2010-07-23 00:00:00

The book EPOC: Diagnóstico diferencial was launched in late June by both IAMR research group member Dr. Marc Miravitlles and Director of Pneumology Service in the Germans Trias i Pujol university Hospital Dr. Josep Morera.

The IAMR Group successfully finishes the workpackage 4 of the MOSAR European Study to Reduce Resistance to Antibiotics

2010-07-16 00:00:00

MOSAR is an international multicenter project funded by the European Union that monitors resistances to antibiotics presented by nosocomial bacteria. The main objective of the project is to inform health care professionals on strategies to combat resistances and prevent the propagation of infectious agents throughout the community. MOSAR involves the participation of 9 countries of the European Union, 50 centers and a budget of €12 million.

Jacob Sellarés successfully defended his doctoral thesis: physiopathology and role of Non-invasive ventilation in weaning failure

2010-07-05 00:00:00

Jacob Sellarés is a Hospital Clínic de Barcelona pulmonologist and he is an IAMR research group member. Since he started working in Clínic 5 years ago, his research has focused on the mechanical ventilation weaning process, technically known as weaning. The room 11 of the Universitat de Barcelona Faculty of Medicine held last June the 30th the public defence of his doctoral thesis. The thesis tribunal comprised Dr. Antoni Ferrer (Hospital del Mar), Dr. Jordi Mancebo (Hospital de Sant Pau) and Dr. Andrés Esteban (Hospital Universitario de Getafe).

43th SEPAR Congress to be held in Galicia

2010-06-23 00:00:00

Palacio de Exposiciones y Congresos in A Coruña, Galicia, will hold from June 25th until June 28th the next 43th Spanish Society of Pneumology and Thoracic Surgery Congress.

The microenvironment in the lung modulates the activation of macrophages leading to different patterns of inflammatory response

2010-06-15 00:00:00

In large series of nonresponding community-acquired pneumonia (CAP) patients, chronic obstructive pulmonary disease (COPD) was observed to be a protective factor for nonresponse to initial antibiotics. This intriguing fact may be linked to changes in the phenotype of inflammatory cells and, in particular, to the induction of classical-M1 or alternative-M2 activation of macrophages, which result in different inflammatory profiles.